9 Papers
Cong Wang is an academic researcher from Tianjin Medical University Cancer Institute and Hospital. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 4, co-authored 7 publications.
Chat about Author
Papers
Rhamnetin induces apoptosis in human breast cancer cells via the miR-34a/Notch-1 signaling pathway.
Lan Lan,Yue Wang,Zhanyu Pan,Bin Wang,Zhensong Yue,Zhansheng Jiang,Ling Li,Cong Wang,Hongmei Tang +8 more
TL;DR: The results of the present study demonstrated that rhamnetin induced apoptosis in human breast cancer cells via the miR-34a/Notch-1 signaling pathway.
Efficacy of Traditional Chinese Medicine in Treatment and Prophylaxis of Radiation-Induced Oral Mucositis in Patients Receiving Radiotherapy: A Randomized Controlled Trial.
Cong Wang,Peiguo Wang,Huaqiang Ouyang,Jing Wang,Lining Sun,Yanwei Li,Dongying Liu,Zhansheng Jiang,Bin Wang,Zhanyu Pan +9 more
TL;DR: CHIN presented an obvious advantage in preventing radiation-induced oral mucositis compared with rhEGF spray, and body mass index in the treatment group exhibited advantage over control group after radiotherapy.
29
Apatinib prevents natural killer cell dysfunction to enhance the efficacy of anti-PD-1 immunotherapy in hepatocellular carcinoma.
TL;DR: Treatment with apatinib resulted in attenuation of tumor growth and increased tumor vessel normalization and results indicated that natural killer cells, but not CD4 + or CD8 + T cells mediated the therapeutic efficacy of apatinIB in HCC mouse models.
27
Icotinib alone or with bevacizumab as first-line therapy in Chinese patients with advanced nonsquamous non-small cell lung cancer and activating EGFR mutations: A retrospective study
TL;DR: In this paper, the authors compared the safety and therapeutic effects between icotinib monotherapy and bevacizumab combined therapy in non-small cell lung cancer (NSCLC) cases harboring EGFR mutations.
4
Real-world validation of the chemotherapy-induced nausea and vomiting predictive model and its optimization for identifying high-risk Chinese patients
Linlin Zhang,Lili Zeng,Yinjuan Sun,Jing Wang,Cong Wang,Chang Liu,Ming Ding,Manman Quan,Zhanyu Pan,Diansheng Zhong +9 more
TL;DR: Zhou et al. as mentioned in this paper developed different CINV risk predictive models incorporating all of the aforementioned factors to guide individualized antiemetic prevention, including expectancy, female sex, younger age, history of morning sickness and anxiety.
1